4.6 Editorial Material

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

Journal

EUROPEAN RESPIRATORY JOURNAL
Volume 51, Issue 6, Pages -

Publisher

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.00848-2018

Keywords

-

Funding

  1. French National Institute for Health and Medical Research (INSERM)
  2. University of Paris-Sud
  3. University Paris-Saclay
  4. Marie Lannelongue Hospital
  5. French National Agency for Research (ANR) [ANR-16-CE17-0014]
  6. Fondation de la Recherche Medicale (FRM) [DEQ20150331712]
  7. Departement Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO)
  8. Assistance Publique-Hopitaux de Paris (AP-HP), Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe
  9. LabEx LERMIT [ANR-10-LABX-0033]
  10. French PAH patient association (HTAP France)
  11. French Fonds de Dotation Recherche en Sante Respiratoire -(FRSR) -Fondation du Souffle (FdS)
  12. Agence Nationale de la Recherche (ANR) [ANR-16-CE17-0014] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available